NEURONES: Declaration Of Transactions On Treasury Shares (March 23 To 27, 2026)

2026-03-30 07:31:04

(MENAFN- GlobeNewsWire - Nasdaq) Nanterre, March 30, 2026

Declaration of transactions on treasury shares
(period from 23 to 27 March 2026)

As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 23 and 27, 2026 (ISIN code FR0004050250):

Day	Total daily volume (in number of shares)	Weighted average price (unit daily)
03/23/2026	46,392	34.13 €
03/24/2026	42,993	33.47 €
03/25/2026	11,665	34.58 €
03/26/2026	7,166	34.26 €
03/27/2026	6,805	34.43 €
Total	115,021

As of March 27, 2026, excluding the liquidity contract, NEURONES now holds 230,861 of the 24,328,716 shares comprising the company's capital (i.e., 0.95%).

All press releases relating to the share buyback program are published in the "Regulated Information" section (under "Weekly declarations of the share buyback transactions" and "Share buyback programs") of the company's website.

About NEURONES

With over 7,300 experts, and ranking among the French leaders in consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, embrace AI, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment A - NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible

Press Relations:
O'Connection
Julia Philippe-Brutin
Tel.: +33 (0)6 03 63 06 03
...

NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
...

Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
...

Attachment

neurones-weekly-declaration-transactions-treasury-shares-march-23-to-27-2026

MENAFN30032026004107003653ID1110917958

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.